Publications by authors named "Anna L Fisse"

Background: Short-chain fatty acids (SCFAs), including propionic acid (PA), are key in immunological research. Supplementing PA has shown benefits for autoimmune diseases. A comprehensive understanding of the PA pharmacokinetics is essential for the optimal design and execution of studies utilizing orally administered PA.

View Article and Find Full Text PDF

Background: Diagnosing chronic inflammatory demyelinating polyneuropathy (CIDP) can be challenging, leading to delays in initiating therapy. As disability in CIDP is mainly dependent on axonal damage, the impact of delayed immunotherapy remains unclear. We multimodally investigated the clinical outcomes of patients with early CIDP regarding different treatment strategies and time points.

View Article and Find Full Text PDF

Objective: Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is an autoimmune neuropathy characterized by progressive or relapsing-remitting weakness and sensory deficits. This study aims to evaluate the utility of corneal confocal microscopy (CCM) in diagnosing and monitoring CIDP.

Methods: We analysed 100 CIDP patients and 31 healthy controls using CCM to measure corneal nerve fiber density (CNFD), length (CNFL), and branch density (CNBD).

View Article and Find Full Text PDF
Article Synopsis
  • A study found that polyneuropathy (PNP) is common in patients with Parkinson's disease (PD), affecting around 65.85% of participants at the start and deteriorating in 21.95% over 2 years.
  • The research included comprehensive evaluations and nerve conduction studies to assess PNP, which was linked to older age and more severe PD symptoms.
  • The findings highlight the need for more extensive studies to understand the relationship between PD and PNP, particularly the progression and underlying mechanisms involved.
View Article and Find Full Text PDF
Article Synopsis
  • Multiple sclerosis is a disease where the immune system attacks the nervous system, making it hard to find effective treatments to fully fix it.
  • Scientists are studying how diet, especially high-fiber foods, can help by producing beneficial substances like propionic acid, which might help protect nerve cells.
  • In experiments, they found that propionic and butyric acid helped damaged nerve cells recover better, which could lead to new ways to help people with multiple sclerosis.
View Article and Find Full Text PDF

Introduction: The value of a sural nerve biopsy for the diagnosis of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is controversial. Evidence-based recommendations for its implementation are lacking. We investigated factors leading to biopsy and analyzed biopsy outcomes and consequences, assessed the predictability of biopsy outcomes through clinical parameters to avoid unnecessary biopsies, and compared results with electrophysiological and clinical severity to determine their prognostic value.

View Article and Find Full Text PDF

Background And Purpose: Nerve cross-sectional area (CSA) is not constant over the human lifespan. The relationship between an increasing CSA and age has been described as a linear positive correlation, but few studies have found a linear decrease in nerve size with older age. The aim of the present study was to analyze the development of nerve CSA in a healthy population from early childhood to old age using high-resolution ultrasound.

View Article and Find Full Text PDF

Purpose: Corneal confocal microscopy is a noninvasive imaging technique to analyze corneal nerve fibers and corneal inflammatory cells (CICs). The amount of CICs is a potential biomarker of disease activity in chronic autoinflammatory diseases. To date, there are no standardized criteria for the morphological characterization of CICs.

View Article and Find Full Text PDF

Introduction: Blood-cerebrospinal fluid (CSF) barrier dysfunction is pivotal for diagnosing immune-mediated neuropathies, especially in spinal nerve root inflammation. Typically, either total CSF protein or the CSF to serum albumin ratio (Q) is measured. Total CSF protein measurements have limitations, notably its fixed reference value regardless of age, in contrast to the age-dependent reference for Q.

View Article and Find Full Text PDF

Background And Purpose: Chronic inflammatory demyelinating polyneuropathy (CIDP) is an autoimmune disease with humoral and cellular autoimmunity causing demyelination of peripheral nerves, commonly treated with intravenous immunoglobulins (IVIg). The neonatal Fc receptor (FcRn), encoded by the FCGRT gene, prevents the degradation of immunoglobulin G (IgG) by recycling circulating IgG. A variable number of tandem repeat (VNTR) polymorphism in the promoter region of the FCGRT gene is associated with different expression levels of mRNA and protein.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to assess the effectiveness of magnetic resonance neurography (MRN) for tracking changes in patients with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) over time.
  • Researchers examined 12 CIDP patients in 2016 and again in 2022, comparing nerve metrics with healthy individuals and correlating findings with clinical tests.
  • Key findings showed that nerve cross-sectional area (CSA) decreased over 6 years in CIDP patients, with initial CSA levels possibly indicating the severity of the disease's course and treatment response.
View Article and Find Full Text PDF

Background: Depression has a major impact on the disease burden of multiple sclerosis (MS). Analyses of overlapping MS and depression risk factors [smoking, vitamin D (25-OH-VD) and Epstein-Barr virus (EBV) infection] and sex, age, disease characteristics and neuroimaging features associated with depressive symptoms in early MS are scarce.

Objectives: To assess an association of MS risk factors with depressive symptoms within the German NationMS cohort.

View Article and Find Full Text PDF

Introduction: Serum neurofilament light chain (sNfL) is a marker for axonal degeneration. Patients with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) often report a fluctuation of symptoms throughout one treatment cycle with intravenous immunoglobulins (IVIG). The aim of this study was to determine whether sNfL is suitable to quantify patient-reported symptom fluctuations.

View Article and Find Full Text PDF

Purpose Of Review: The purpose if this review is to provide an overview of the available data on the use of nerve ultrasound for the diagnosis and follow-up of peripheral neuropathies.

Recent Findings: During the last decade, nerve ultrasound has been established as a complementary tool for the evaluation of morphological changes mostly for immune-mediated polyneuropathies. Through the development of ultrasound protocols for evaluation of disease-specific sites, nerve ultrasound has proven to be a practical, widely available, reproducible diagnostic tool with no relevant contraindications.

View Article and Find Full Text PDF
Article Synopsis
  • - This study aimed to explore autonomic function in Parkinson's disease by using various methods such as clinical assessments, a head-up tilt test, and ultrasound imaging of the vagus nerve among 80 patients.
  • - Results showed that Parkinson's patients had a significantly smaller cross-sectional area of the vagus nerve compared to healthy individuals and those with chronic inflammatory demyelinating polyneuropathy, with the right nerve being larger than the left in all groups.
  • - The head-up tilt test revealed that 43 patients had autonomic dysfunction, with specific conditions like orthostatic hypertension and chronotropic incompetence, and the vagal nerve size was related to heart rate and parasympathetic function during the test.
View Article and Find Full Text PDF

In inflammatory neuropathies, oxidative stress results in neuronal and Schwann cell (SC) death promoting early neurodegeneration and clinical disability. Treatment with the short-chain fatty acid propionate showed a significant immunoregulatory and neuroprotective effect in multiple sclerosis patients. Similar effects have been described for patients with chronic inflammatory demyelinating polyneuropathy (CIDP).

View Article and Find Full Text PDF

Introduction: SARS-CoV-2 pandemic is especially compromising for patients with autoimmune diseases with or without immunomodulatory treatment. This study aimed to investigate the longitudinal changes in the health care of patients with immune-mediated neuropathies during the COVID-19 pandemic.

Methods: We performed a longitudinal study using questionnaires in a prospective cohort of patients with immune-mediated neuropathies at two timepoints of the pandemic: May-July 2021 and May-July 2022.

View Article and Find Full Text PDF

Autoimmune neuropathy associated with antibodies against pan-neurofascin is a new subtype of nodo-paranodopathy. It is relevant because it is associated with high morbidity and mortality. Affected patients often require intensive care unit treatment for several months, and data on the reversibility and long-term prognosis are limited.

View Article and Find Full Text PDF

Background: Diagnosis and treatment of patients with immune-mediated neuropathies is challenging due to the heterogeneity of the diseases.

Objectives: To assess similarities and differences in the current care of patients with immune-mediated polyneuropathies in specialized centers in Germany within the German neuritis network "Neuritis Netz".

Material And Methods: We conducted a cross-sectional survey of nine neurological departments in Germany that specialize in the care of patients with immune-mediated neuropathies.

View Article and Find Full Text PDF

Echogenicity of peripheral nerves in high-resolution ultrasound (HRUS) provides insight into the structural damage of peripheral nerves in various polyneuropathies. The aim of this study was to compare nerve echogenicity in different primarily axonal or demyelinating polyneuropathies to examine the significance of this parameter. Performing semi-automated echogenicity analysis and applying Image J, we retrospectively used HRUS images of 19 patients with critical illness polyneuropathy (CIP), and 27 patients with chemotherapy-induced polyneuropathy (CIN) and compared them to 20 patients with chronic inflammatory demyelinating polyneuropathy (CIDP).

View Article and Find Full Text PDF
Article Synopsis
  • This study focuses on the prevalence and impact of pain, fatigue, and depression in patients with chronic inflammatory demyelinating polyneuropathy (CIDP), highlighting that these factors are often overlooked compared to motor dysfunction.
  • Among the 84 patients studied, 62% reported experiencing pain, with neuropathic pain significantly linked to higher levels of fatigue and depression, suggesting that pain is a serious contributor to disability.
  • The findings indicate that managing chronic pain and assessing sensory dysfunction are crucial for improving the quality of life in CIDP patients, underscoring the need for a comprehensive evaluation of all disability factors.
View Article and Find Full Text PDF
Article Synopsis
  • Chronic inflammatory demyelinating polyneuropathy (CIDP) can be difficult to differentiate from non-inflammatory axonal polyneuropathies (NIAPs), especially when secondary axonal damage is present.
  • This study compared nerve ultrasounds of patients with CIDP and NIAP to see if measurements could help distinguish between the two conditions, leading to the creation of a new scoring system called the adjusted Bochum ultrasound score (aBUS).
  • Results showed that nerve ultrasounds can enhance diagnostic accuracy, with aBUS offering improved specificity and sensitivity compared to traditional electrophysiological criteria, making it a valuable tool for diagnosing CIDP.
View Article and Find Full Text PDF

Nerve ultrasound is increasingly used in the differential diagnosis of polyneuropathy as a complementary tool to nerve conduction studies. Morphological alterations of the peripheral nerves, such as increasing the cross-sectional area (CSA), have been described in various immune-mediated polyneuropathies. The most prominent morphological changes in nerve ultrasound have been described for the chronic inflammatory demyelinating polyneuropathy (CIDP)-spectrum disease.

View Article and Find Full Text PDF
Article Synopsis
  • Monitoring CIDP is complex due to unclear links between disability, subtype, and nerve damage, prompting a study to assess how different electrophysiological variables relate to patient outcomes.
  • The study involved 95 patients undergoing nerve conduction studies and clinical assessments to identify correlations between nerve function indicators and disability scores over time.
  • Results indicated that axonal damage, particularly in typical CIDP cases, strongly correlates with clinical disability, suggesting that focusing on axonal degeneration markers could improve monitoring and understanding of disease progression.
View Article and Find Full Text PDF
Article Synopsis
  • Recent studies have identified inflammatory neuropathies that involve the nodes of Ranvier and are caused by specific autoantibodies, particularly anti-pan-NF-associated neuropathies, which are rare and can be life-threatening.
  • A case of a 52-year-old male with this condition showed rapid progression to a severe "locked-in" syndrome, despite initial treatment, and was characterized by specific antibody presence and non-excitable nerves.
  • A combination of aggressive immunotherapy, including rituximab and bortezomib, led to significant clinical improvement and normalization of nerve function over three months, suggesting this combination may be an effective treatment for these rare neuropathies.*
View Article and Find Full Text PDF